Derivative Liabilities (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|---|
Mar. 12, 2021 |
Nov. 06, 2020 |
Jul. 29, 2021 |
Jun. 30, 2022 |
Jun. 30, 2022 |
Feb. 23, 2021 |
|
| Public SPAC Warrants [Member] | ||||||
| Derivative Liabilities (Details) [Line Items] | ||||||
| Warrant, description | Each Public SPAC Warrant entitles the holder to purchase one-half of one share of the Company’s common stock at an exercise price of $5.75 per half share ($11.50 per whole share) until November 6, 2025, subject to adjustment. No fractional shares will be issued upon exercise of the Public SPAC Warrants. Management has determined that the Public SPAC Warrants contain a tender offer provision which could result in the Public SPAC Warrants settling for the tender offer consideration (including potentially cash) in a transaction that didn’t result in a change-in-control. This feature results in the Public SPAC Warrants being precluded from equity classification. Accordingly, the Public SPAC Warrants are classified as liabilities measured at fair value, with changes in fair value each period reported in earnings | |||||
| Revalued warrant | $ 1,838,850 | $ 1,838,850 | ||||
| Fair value of the derivative liabilities | 4,357,350 | 6,210,000 | ||||
| PIPE Warrants [Member] | ||||||
| Derivative Liabilities (Details) [Line Items] | ||||||
| Revalued warrant | 621,600 | 621,600 | ||||
| Fair value of the derivative liabilities | 2,849,900 | $ 5,894,700 | ||||
| Purchase of shares of common stock (in Shares) | 2,564,000 | |||||
| Exercise price per share (in Dollars per share) | $ 5 | |||||
| Fair value of PIPE warrants | $ 7,294,836 | |||||
| Initial Public Offering [Member] | Public SPAC Warrants [Member] | ||||||
| Derivative Liabilities (Details) [Line Items] | ||||||
| Aggregate amount (in Shares) | 11,500,000 | |||||
| Private SPAC Warrants [Member] | ||||||
| Derivative Liabilities (Details) [Line Items] | ||||||
| Aggregate amount (in Shares) | 502,500 | |||||
| Warrant, description | Each Private SPAC Warrant entitles the holder to purchase one-half of one share of the Company’s common stock at an exercise price of $5.75 per half share ($11.50 per whole share) until November 6, 2025, subject to adjustment. No fractional shares will be issued upon exercise of the Private SPAC Warrants. Management has determined that the Private SPAC Warrants contain a tender offer provision which could result in the Private SPAC Warrants settling for the tender offer consideration (including potentially cash) in a transaction that didn’t result in a change-in-control. This feature (amongst others) results in the Private SPAC Warrants being precluded from equity classification. | |||||
| Revalued warrant | 30,150 | $ 30,150 | ||||
| Fair value of the derivative liabilities | 185,925 | 437,175 | ||||
| Alpha Warrant [Member] | ||||||
| Derivative Liabilities (Details) [Line Items] | ||||||
| Revalued warrant | 1,720 | 1,720 | ||||
| Fair value of the derivative liabilities | 18,311 | 41,841 | ||||
| Fair value of PIPE warrants | 95,677 | 95,677 | ||||
| Purchase of aggregate shares (in Shares) | 25,000 | |||||
| Exercise price per share (in Dollars per share) | $ 7.07 | |||||
| Beneficial ownership | 4.99% | |||||
| AGP Warrant [Member] | ||||||
| Derivative Liabilities (Details) [Line Items] | ||||||
| Revalued warrant | 10,395 | 10,395 | ||||
| Fair value of the derivative liabilities | $ 76,052 | $ 133,936 | ||||
| Exercise price per share (in Dollars per share) | $ 5.28 | |||||
| Purchase of aggregate shares (in Shares) | 63,658 | 63,658 | ||||
| Exercise price per share (in Dollars per share) | $ 5.28 | |||||
| Beneficial ownership | 4.99% |